Literature DB >> 20102897

Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation.

Eleftherios M Kallergis1, Emmanuel G Manios, Emmanuel M Kanoupakis, Hercules E Mavrakis, Christos A Goudis, Niki E Maliaraki, Ilias G Saloustros, Maria E Milathianaki, Gregory I Chlouverakis, Panos E Vardas.   

Abstract

Because humoral alterations have been implicated in the generation and perpetuation of atrial fibrillation (AF), we aimed to elucidate possible abnormalities in atrial endocrine function in the setting of lone AF. Levels of plasma apelin and amino terminal fragment of the brain natriuretic peptide prohormone (NT-pro-BNP) were measured in 40 patients with persistent AF, before and 1 month after electrical cardioversion, and in 15 controls in sinus rhythm (SR). All patients were successfully cardioverted to SR, although in 9 of them AF recurred. Baseline apelin levels were lower and NT-pro-BNP levels higher in patients with AF compared to controls (380 +/- 186 vs 700 +/- 151 pg/ml, p <0.001, and 615 +/- 611 vs 50 +/- 28 pg/ml, p <0.001, respectively). Maintenance of SR resulted in an increase of apelin and a decrease of NT-pro-BNP levels during the postcardioversion follow-up period compared to baseline (497 +/- 170 vs 368 +/- 178 pg/ml, p <0.001, and 206 +/- 106 vs 398 +/- 269 pg/ml, p <0.001 respectively). Patients who developed AF recurrence by the end of the follow-up period had similar values of apelin and NT-pro-BNP on final and initial evaluations (444 +/- 142 vs 422 +/- 217 pg/ml, p = 0.62, and 1,328 +/- 714 vs 1,362 +/- 862 pg/ml, p = 0.74, respectively). Stepwise logistic regression analysis showed that left atrial diameter (b =-0.49, p = 0.05), and baseline NT-pro-BNP (b = 0.006, p = 0.022), but not apelin, were independent predictors for AF recurrence. In conclusion, this study suggests that endocrine heart function, as judged from apelin and NT-pro-BNP levels, is reversibly modified in the setting of lone AF. This could influence systemic hemodynamics and pharmacologic measures designed to treat this arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20102897     DOI: 10.1016/j.amjcard.2009.08.656

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

1.  NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.

Authors:  Jinqi Fan; Hua Cao; Li Su; Zhiyu Ling; Zengzhang Liu; Xianbin Lan; Yanping Xu; Weijie Chen; Yuehui Yin
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

2.  A combination of P wave electrocardiography and plasma brain natriuretic peptide level for predicting the progression to persistent atrial fibrillation: comparisons of sympathetic activity and left atrial size.

Authors:  Yasushi Akutsu; Kyouichi Kaneko; Yusuke Kodama; Fumito Miyoshi; Hui-Ling Li; Norikazu Watanabe; Taku Asano; Kaoru Tanno; Jumpei Suyama; Atsuo Namiki; Takehiko Gokan; Youichi Kobayashi
Journal:  J Interv Card Electrophysiol       Date:  2013-09-13       Impact factor: 1.900

3.  Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Mark Ainslie; Virginia Mplani; Georgia Karavasili; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

4.  Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.

Authors:  Theodoros A Zografos; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

5.  Relation of hs-CRP and BNP levels with the atrial spontaneous echo contrast and thrombi in permanent atrial fibrillation patients with different etiologies.

Authors:  Tayfun Sahin; Eser Acar; Umut Celikyurt; Teoman Kılıc; Guliz Kozdag; Aysen Agacdiken; Dilek Ural
Journal:  Med Sci Monit       Date:  2012-02

6.  Apelin and pulmonary hypertension.

Authors:  Charlotte U Andersen; Ole Hilberg; Søren Mellemkjær; Jens E Nielsen-Kudsk; U Simonsen
Journal:  Pulm Circ       Date:  2011 Jul-Sep       Impact factor: 3.017

7.  Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges.

Authors:  Seyyed M R Kazemi-Bajestani; Vaibhav B Patel; Wang Wang; Gavin Y Oudit
Journal:  Cardiol Res Pract       Date:  2012-05-13       Impact factor: 1.866

8.  Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainide.

Authors:  Ahmad Shoaib Amin; René H J Peters; Maaike Verstraaten; Arthur A M Wilde; Eugène M Buijs
Journal:  Neth Heart J       Date:  2015-03       Impact factor: 2.380

9.  TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice.

Authors:  Robert Stöhr; Ben Arpad Kappel; Daniela Carnevale; Michele Cavalera; Maria Mavilio; Ivan Arisi; Valentina Fardella; Giuseppe Cifelli; Viviana Casagrande; Stefano Rizza; Antonino Cattaneo; Alessandro Mauriello; Rossella Menghini; Giuseppe Lembo; Massimo Federici
Journal:  Mol Metab       Date:  2015-08-06       Impact factor: 7.422

10.  Apelin Ameliorates High Glucose-Induced Downregulation of Connexin 43 via AMPK-Dependent Pathway in Neonatal Rat Cardiomyocytes.

Authors:  Xiaoting Li; Lu Yu; Jing Gao; Xukun Bi; Juhong Zhang; Shiming Xu; Meihui Wang; Mengmeng Chen; Fuyu Qiu; Guosheng Fu
Journal:  Aging Dis       Date:  2018-02-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.